FNY Investment Advisers’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,100
Closed -$935K 891
2022
Q3
$935K Buy
+18,100
New +$748K 0.65% 39

Other funds holding CCXI

FNY Investment Advisers's CCXI Position: Q4 2022 in Review

FNY Investment Advisers sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 18,100 shares — an estimated $935K sold.

FNY Investment Advisers first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $935K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • FNY Investment Advisers reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 18,100 ChemoCentryx, Inc. shares in Q4 2022, an estimated $935K.
  • FNY Investment Advisers first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • FNY Investment Advisers's ChemoCentryx, Inc. position peaked at $935K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on FNY Investment Advisers's 13F filing for Q4 2022, filed 10 Jan 2023.